Rodman & Renshaw is agent; proceeds fund general corporate purposes
By Devika Patel
Knoxville, Tenn., Dec. 23 - Oculus Innovative Sciences, Inc. said it arranged a registered direct offering of stock to raise about $2 million.
The company will sell about 1.8 million common shares at $1.15 apiece. The price per share is an 11.54% discount to the Dec. 22 closing share price, $1.30.
Rodman & Renshaw, LLC is the agent.
Settlement is expected on Dec. 28.
Proceeds will be used for general corporate purposes, including several important growth opportunities.
Petaluma, Calif.-based Oculus develops and markets products for the prevention and elimination of infection in chronic and acute wounds.
| Issuer: | Oculus Innovative Sciences, Inc.
|
| Issue: | Common stock
|
| Amount: | $2 million (approximate)
|
| Shares: | 1.8 million (approximate)
|
| Price: | $1.15
|
| Warrants: | No
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | Dec. 23
|
| Settlement date: | Dec. 28
|
| Stock symbol: | Nasdaq: OCLS
|
| Stock price: | $1.30 at close Dec. 22
|
| Market capitalization: | $31.21 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
